These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25387190)

  • 21. HPV vaccine and males: issues and challenges.
    Zimet GD; Rosenthal SL
    Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of the human papillomavirus vaccine among urban adolescent males.
    Gutierrez B; Leung A; Jones KT; Smith P; Silverman R; Frank I; Leader AE
    Am J Mens Health; 2013 Jan; 7(1):27-36. PubMed ID: 22892147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery.
    Holder NA; Katzenellenbogen R; Middleman AB
    J Adolesc Health; 2013 Sep; 53(3):423-5. PubMed ID: 23830089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
    Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
    Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Struggles within Japan's national HPV vaccination: A proposal for future strategy.
    Tanaka Y; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2017 May; 13(5):1167-1168. PubMed ID: 28059676
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland.
    Woodhall SC; Lehtinen M; Verho T; Huhtala H; Hokkanen M; Kosunen E
    J Adolesc Health; 2007 May; 40(5):466-9. PubMed ID: 17448408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
    Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
    Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
    Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early sexual debut warrants HPV vaccination at an earlier age.
    Berenson AB; Croisant S
    Vaccine; 2017 Mar; 35(9):1195-1196. PubMed ID: 28162826
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus vaccine update.
    Gilmer LS
    Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV vaccination.
    Dilley S; Miller K; Huh W
    Gynecol Oncol; 2018 Jan; 148(1):3-4. PubMed ID: 29246414
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding human papillomavirus vaccine uptake.
    Fisher WA
    Vaccine; 2012 Nov; 30 Suppl 5():F149-56. PubMed ID: 23199958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
    Grant LA; Dunne EF; Chesson H; Markowitz LE
    Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting the immunization neighborhood: Benefits and challenges of pharmacies as additional locations for HPV vaccination.
    Rothholz M; Tan LL
    Hum Vaccin Immunother; 2016 Jun; 12(6):1646-8. PubMed ID: 27191364
    [No Abstract]   [Full Text] [Related]  

  • 37. The content and context of physicians' communication with males about human papillomavirus vaccination.
    Malo TL; Ali KN; Sutton SK; Perkins RB; Giuliano AR; Vadaparampil ST
    Hum Vaccin Immunother; 2016 Jun; 12(6):1511-8. PubMed ID: 26835599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indications for the HPV vaccine in adolescents: a review of the literature.
    Soares GR; Vieira Rda R; Pellizzer EP; Miyahara GI
    J Infect Public Health; 2015; 8(2):105-16. PubMed ID: 25453595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does intention to recommend HPV vaccines impact HPV vaccination rates?
    Feemster KA; Middleton M; Fiks AG; Winters S; Kinsman SB; Kahn JA
    Hum Vaccin Immunother; 2014; 10(9):2519-26. PubMed ID: 25483470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Virginia's School-Entry Vaccine Mandate on Human Papillomavirus Vaccination Among 13-17-Year-Old Females.
    Pierre-Victor D; Page TF; Trepka MJ; Stephens DP; Li T; Madhivanan P
    J Womens Health (Larchmt); 2017 Mar; 26(3):266-275. PubMed ID: 27697003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.